• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对包括冠状病毒在内的传染性病毒疾病进行治疗的古兰经和先知药用植物的计算机分析。

In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus.

作者信息

Mehmood Azhar, Khan Suliman, Khan Sajid, Ahmed Saeed, Ali Ashaq, Xue Mengzhou, Ali Liaqat, Hamza Muhammad, Munir Anum, Ur Rehman Saad, Mehmood Khan Arshad, Hussain Shah Abbas, Bai Qian

机构信息

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of Bioinformatics/Botany, Govt. Postgraduate College Mandian Abbottabad, KPK, Pakistan.

出版信息

Saudi J Biol Sci. 2021 May;28(5):3137-3151. doi: 10.1016/j.sjbs.2021.02.058. Epub 2021 Feb 23.

DOI:10.1016/j.sjbs.2021.02.058
PMID:33642896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7899931/
Abstract

Coronavirus disease (COVID-19) is an infection of the respiratory system caused by single standard RNA viruses named as Severe Acute Respiratory Syndrome 2 (SARS-CoV-2). The disease appeared as a serious problem and the leading cause of death in human beings throughout the world. The main source of different phytochemicals are plants, which helps in the development of new drugs against various ailments. Islam is comprehensive religion and a complete code of life for Muslims. The teaching of Islam, according to the Holy Quran and Hadith are universal for the benefit of humanity. Islam believes that every ailment is from God and who made the disease definitely made its medication. There is a complete guideline with regard to taking measures against infectious diseases such as quarantine and seeking medicinal treatment. The research objective is to gather the knowledge of medicinal plants described in the Holy Quran or utilized by the Prophet (SAW) for the treatment of different ailments or advised to use them to boost immunity and strengthen the body. Scientists across the globe have found these plants beneficial for many diseases and have antiviral potential. In present study, the six plant species including and were selected which contain phytochemicals like Calcium Elenolate, Thymoquinone, S-Allylcysteine, Dipropyl Disulfide, Sesquiterpene, Monoterpene, Pelargonidin 3-Galactoside ion and Kaempferol. The phytochemicals monoterpene (from ) shows best interaction with target proteins RdRP, 3CLPro, ACE2. Calcium Elonate (from olive) bonds with 3CLPro, ACE2 and Kemoferol and Pelargomidine (from Senna Makki) bonds with RdRP, ACE2. The ligands show a unique set of intersections i.e. hydrogen bonding, and alkyl interaction. These medicinal plants can be utilized immediately for the treatment of COVID-19 as their safety is already established. This treatment can enhance recovery when combined with other treatments. Furthermore, the screening of bioactive compounds or phytochemicals found in these plants can be utilized to design new therapeutic drug to treat COVID-19 pandemic.

摘要

冠状病毒病(COVID-19)是一种由名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的单链RNA病毒引起的呼吸系统感染。该疾病已成为一个严重问题,是全世界人类死亡的主要原因。不同植物化学物质的主要来源是植物,这有助于开发针对各种疾病的新药。伊斯兰教是全面的宗教,是穆斯林完整的生活准则。根据《古兰经》和圣训,伊斯兰教的教义对全人类有益。伊斯兰教认为,每种疾病都来自真主,创造疾病的真主必定也创造了其治疗方法。对于采取诸如隔离和寻求药物治疗等针对传染病的措施有完整的指导方针。研究目的是收集《古兰经》中描述的或先知(愿主福安之)用于治疗不同疾病或建议用于增强免疫力和强健身体的药用植物的知识。全球科学家已发现这些植物对许多疾病有益且具有抗病毒潜力。在本研究中,选择了六种植物,包括……,它们含有诸如紫铆酸钙、百里醌、S-烯丙基半胱氨酸、二丙基二硫化物、倍半萜、单萜、天竺葵素3-半乳糖苷离子和山奈酚等植物化学物质。植物化学物质单萜(来自……)与目标蛋白RNA依赖性RNA聚合酶(RdRP)、3C样蛋白酶(3CLPro)、血管紧张素转换酶2(ACE2)表现出最佳相互作用。紫铆酸钙(来自橄榄)与3CLPro、ACE2结合,山奈酚和天竺葵素(来自番泻叶)与RdRP和ACE2结合。这些配体表现出独特的一组交叉点,即氢键和烷基相互作用。这些药用植物因其安全性已得到证实,可立即用于治疗COVID-19。这种治疗与其他治疗方法联合使用时可提高康复率。此外,对这些植物中发现的生物活性化合物或植物化学物质的筛选可用于设计治疗COVID-19大流行的新治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/edf60749db1f/gr16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/1386d0749efd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/25958aae25b1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/f8b4cca27cba/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/ec258716e584/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/11fd814c8e44/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/0b40f80b7715/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/6949c8eff147/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/c2be56bc4b7f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/6fb2c4f56b2a/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/772b19c556ef/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/5aa9e2555d54/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/b20bb8975e77/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/2e4449b2527c/gr13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/69c1aacb07a9/gr14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/5f2025c084ba/gr15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/edf60749db1f/gr16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/1386d0749efd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/25958aae25b1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/f8b4cca27cba/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/ec258716e584/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/11fd814c8e44/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/0b40f80b7715/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/6949c8eff147/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/c2be56bc4b7f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/6fb2c4f56b2a/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/772b19c556ef/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/5aa9e2555d54/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/b20bb8975e77/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/2e4449b2527c/gr13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/69c1aacb07a9/gr14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/5f2025c084ba/gr15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/8117035/edf60749db1f/gr16.jpg

相似文献

1
In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus.对包括冠状病毒在内的传染性病毒疾病进行治疗的古兰经和先知药用植物的计算机分析。
Saudi J Biol Sci. 2021 May;28(5):3137-3151. doi: 10.1016/j.sjbs.2021.02.058. Epub 2021 Feb 23.
2
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).药用植物和次生代谢物抗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的作用机制。
Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130.
3
A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19.关于传统阿拉伯或伊斯兰药用植物作为对抗COVID-19辅助疗法的全面观点。
Saudi J Biol Sci. 2023 Mar;30(3):103561. doi: 10.1016/j.sjbs.2023.103561. Epub 2023 Jan 13.
4
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.植物化学制剂对 SARS-CoV 的作用及其在 COVID-19 中应用的选择:一个小型综述。
Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458.
5
Pharmacological Effects of Selected Medicinal Plants and Vitamins Against COVID-19.精选药用植物和维生素对新型冠状病毒肺炎的药理作用
J Food Nutr (Frisco). 2021 Jun;7(2). doi: 10.17303/jfn.2021.7.202. Epub 2021 Jul 12.
6
In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target.针对SARS-CoV-2 TMPRSS2靶点的香料衍生抗病毒植物化学物质的计算机模拟研究。
J Biomol Struct Dyn. 2022;40(22):11874-11884. doi: 10.1080/07391102.2021.1965658. Epub 2021 Aug 24.
7
Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.重新定位 SARS-CoV-2 的治疗方法:基于植物的抗 HIV 化合物的虚拟筛选作为 COVID-19 病毒 RdRp 的可能抑制剂。
Curr Pharm Des. 2022;28(12):969-980. doi: 10.2174/1381612828666220428120939.
8
In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.利用计算机筛选洋葱植物化学物质与 SARS 和 SARS-CoV-2 3CL 样蛋白酶以及 COVID-19 人受体 ACE-2 的结合能力。
Trop Biomed. 2021 Jun 1;38(2):214-221. doi: 10.47665/tb.38.2.060.
9
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.药用植物、植物化学物质和草药对抗包括 SARS-CoV-2 在内的病毒病原体。
Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775.
10
Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.使用来自二十种植物的二十种植物化学物质预防新型冠状病毒感染的潜在联合疗法:一种计算机模拟方法。
Virusdisease. 2021 Mar;32(1):108-116. doi: 10.1007/s13337-021-00658-7. Epub 2021 Apr 5.

引用本文的文献

1
Antimicrobial Potential of Natural Compounds of Zingiberaceae Plants and their Synthetic Analogues: A Scoping Review of and Approaches.姜科植物天然化合物及其合成类似物的抗菌潜力: 和 方法的范围综述。
Curr Top Med Chem. 2024;24(13):1158-1184. doi: 10.2174/0115680266294573240328050629.
2
Ethnomedicinal evaluation of medicinal plants used for therapies by men and women in rural and urban communities in Makkah district.麦加地区城乡社区中男性和女性用于治疗的药用植物的民族药用评价。
Saudi Pharm J. 2024 Jan;32(1):101881. doi: 10.1016/j.jsps.2023.101881. Epub 2023 Dec 2.
3
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.

本文引用的文献

1
How the Oxford-AstraZeneca covid-19 vaccine was made.牛津大学与阿斯利康公司合作研发的新冠疫苗是如何制成的。
BMJ. 2021 Jan 12;372:n86. doi: 10.1136/bmj.n86.
2
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.血管紧张素转化酶 2(ACE2)在 COVID-19 中的作用。
Crit Care. 2020 Jul 13;24(1):422. doi: 10.1186/s13054-020-03120-0.
3
Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.利用计算方法分析 SARS-CoV-2 RNA 依赖性 RNA 聚合酶作为潜在的治疗药物靶标。
通过天然产物对抗 COVID-19:药物化学家的各种尝试的全面更新。
Molecules. 2023 Jun 20;28(12):4860. doi: 10.3390/molecules28124860.
4
The use of herbal and dietary supplements for COVID-19 prevention: A survey among the public in a Malaysian suburban town.使用草药和膳食补充剂预防新冠病毒:对马来西亚一个郊区城镇公众的一项调查。
J Herb Med. 2023 Jun;39:100650. doi: 10.1016/j.hermed.2023.100650. Epub 2023 Mar 22.
5
In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2.基于计算机的方法评估特级初榨橄榄油(EVOO)生物活性成分橄榄苦苷和油橄榄苦苷对 SARS-CoV-2 刺突治疗药物靶点的潜在抗病毒活性。
Molecules. 2022 Nov 4;27(21):7572. doi: 10.3390/molecules27217572.
6
Review on Plant-Based Management in Combating Antimicrobial Resistance - Mechanistic Perspective.基于植物的抗菌耐药性管理综述——机制视角
Front Pharmacol. 2022 Sep 29;13:879495. doi: 10.3389/fphar.2022.879495. eCollection 2022.
7
L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.黄连与 COVID-19:抗 COVID-19 化学成分、临床试验、发明和专利文献一览。
Molecules. 2022 Apr 25;27(9):2750. doi: 10.3390/molecules27092750.
8
An Evaluation of the Potential of Essential Oils against SARS-CoV-2 from In Silico Studies through the Systematic Review Using a Chemometric Approach.通过化学计量学方法进行系统评价,从计算机模拟研究评估精油对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜力。
Pharmaceuticals (Basel). 2021 Nov 10;14(11):1138. doi: 10.3390/ph14111138.
9
Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.从天然产物中筛选 S 蛋白-血管紧张素转化酶 2(ACE2)抑制剂:COVID-19 潜在抑制剂发现的策略和进展。
Eur J Med Chem. 2021 Dec 15;226:113857. doi: 10.1016/j.ejmech.2021.113857. Epub 2021 Oct 4.
J Transl Med. 2020 Jul 7;18(1):275. doi: 10.1186/s12967-020-02439-0.
4
nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of and hydroxychloroquine.nCOV-19 肽质量指纹图谱鉴定、结合和抑制剂黄酮类和蒽醌类以及羟氯喹的阻断。
J Biomol Struct Dyn. 2021 Jul;39(11):4089-4099. doi: 10.1080/07391102.2020.1778534. Epub 2020 Jun 22.
5
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China.中药治疗新型冠状病毒肺炎(COVID-19)的疗效分析:来自中国湖北省武汉市的实证研究
Chin Med. 2020 Apr 15;15:34. doi: 10.1186/s13020-020-00317-x. eCollection 2020.
6
Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants.严重急性呼吸综合征冠状病毒2 3CL的结构基础与药用植物抗新型冠状病毒药物发现
J Pharm Anal. 2020 Aug;10(4):313-319. doi: 10.1016/j.jpha.2020.03.009. Epub 2020 Mar 26.
7
Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19.《中国新冠肺炎诊疗国家指南》中中医一线专家建议要点
Eur J Integr Med. 2020 Jun;36:101116. doi: 10.1016/j.eujim.2020.101116. Epub 2020 Apr 3.
8
Structure of the RNA-dependent RNA polymerase from COVID-19 virus.COVID-19 病毒的依赖 RNA 的 RNA 聚合酶的结构。
Science. 2020 May 15;368(6492):779-782. doi: 10.1126/science.abb7498. Epub 2020 Apr 10.
9
Covid-19: risk factors for severe disease and death.新冠病毒病:重症和死亡的风险因素
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
10
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.